ARCHIVES

FDA Approves NDA For Mylan’s Paclitaxel For Ovarian And Breast Cancer Treatment.

This article is from The Cancer Letter archive.

Vol. 27 No. 30 | July 27, 2001

Download PDF Visit The Full Archive

Related Articles

In Brief: Sartorelli AACI President, McInTyre President Elect; Moertel to Receive ACCC Clinical Award

July 10, 1987

RFPs Go Out To Cooperative Groups for Community Programs

April 9, 1976

Roswell Park Researchers Advocate HPV Vaccination For Boys As Well As Girls

May 29, 2009

In Brief: Mauer Resigns St. Jude Director; Breslow Named DRCCA Board Chairman; Senate Considers Line Items

August 20, 1982

President Signs Interim Money Bill; NCI At $725 Million

July 4, 1975

NCI Programs: Institute Renews 10 Center Grants, Provides Complete Grant List.

January 28, 2005